摘要
本文首先阐述了羟氯喹在系统性红斑狼疮中的应用,其次探讨了在应用中羟氯喹容易发生的一些不良反应。
出处
《医学信息》
2011年第8期2485-2486,共2页
Journal of Medical Information
参考文献9
-
1The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus [J].N Engl J Med,1991,324(3):150-154.
-
2Fessler BJ, Alarc6n GS,McGwin G Jr, et al. Systemic lupus erythematpsus in three ethnic groups XVi.Association of hydroxychloroquine use with reduced risk of damage accruai[J].Arthritis Rheum,2005,52(5):1473-1480.
-
3Fessler BJ, Alarc6n GS,McGwin G Jr, et al. Systemic lupus erythematous in three ethnic groups XVi.Association of hydroxychloroquine use with reduced risk of damage accruai[J].Arthritis Rheum,2005,52(5):1473-1480.
-
4Kasitanon N,Magder LS,Petri M.Predictors of survival in systemic lupus erythematosus[J].Medicine(Baltimore),2006,85 (3): 1472'156.
-
5Kasitanon N, Fine DM,Haas M, et al. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis[J].Lupus,2006,15 (6):366~370.
-
6Rahman P,Gladman DD,Urowitz MB,et al.The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs [Jl.J Rheumatol,1999,26(2):325 -330.
-
7周纬,殷蕾,杨珍.泼尼松与羟氯喹联合治疗轻型儿童系统性红斑狼疮临床观察[J].中国当代儿科杂志,2005,7(6):545-546. 被引量:4
-
8张羽,杨静.小剂量激素联合甲氨蝶呤、羟氯喹治疗系统性红斑狼疮的临床观察[J].西部医学,2010,22(11):2081-2082. 被引量:15
-
9D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus [J]. Lancet,2007,369(9561):587-596.
二级参考文献16
-
1Mork CC,lee KW,Ho CT,et al.A prospective study of survival and prognostic indicators of systemic lupus erythematatosus in a souther Chinese population[J].Rheuatolgy,2004,39:399-406.
-
2Iriya SM,Capelozzi VC,Ca Cich I,et al.Causes of death in patients with Systemic lupus erthematosus in Sao Paulo,Brazil:a study of 113 autopsie[J].Arch inter Med,2005,161:1557.
-
3Cervera R,Khamashta Mhamashta MA,Font J,et al.Morbidity and mortality in systemic lupus erthematosus during a 5-year period:a multi-center prospective study of 1000ptients.Eeropean working party on Systemic lupus Erthematosus[J].Medicine(Baltimore),2004,78:167-175.
-
4The Canadian Hydroxychloroquine Study Group.A ran-domized study of the effect of withdrawing hydroxychloroquinesulfate in systemic lupus erythematosus[J].N Engl J Med,2005,324(3)150-155.
-
5Fessler BJ,Alarc(o)n GS,Mc Gwin G Jr,et al.Systemiclupus erythematosus in three ethnic groups:ⅩⅥ.Association of hydroxychloroquine use with reduced risk of damage accrual[J].Arthritis Rheum,2005,52(5):1473-1480.
-
6Alarc(o)n GS,Roseman JM,McGwin G JR,et al.Systemiclupus erythematosus in three ethnic groups.ⅩⅩ.Damageas a predictor of further damage[J].Rheumatology(Oxford),2004,43(2):202.
-
7Rahman P,Gladman DD,Urowitz MB,et al.The choles-terol lowering effect of antimalarial drugs is enhanced inpatients with lupus taking corticosteroid drugs[J].JRheumatol,2004,26(2):325-330.
-
8叶益新 张江林 黄烽 蒋明 David YU 林孝义 朱立平.抗疟药[A].蒋明,David YU,林孝义,朱立平.中华风湿病学[M].北京:华夏出版社,2004.1738-1745.
-
9Nossent JC. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteriod therapy, and prognosis[J].J Rheumatol, 1998, 25(4):654-659.
-
10Gloor JM. Lupus nephritis in children[J]. Lupus, 1998,7(9):639-643.
共引文献17
-
1唐雪栋,林瑞霞,黄丽君.39例不同性别儿童系统性红斑狼疮肾炎临床特征初探[J].中国当代儿科杂志,2008,10(2):236-238. 被引量:3
-
2无.儿童系统性红斑狼疮诊疗建议[J].中华儿科杂志,2011,49(7):506-514. 被引量:40
-
3罗成城.甲氨蝶呤和左旋咪唑治疗红斑狼疮的临床疗效分析[J].海峡药学,2012,24(12):103-104. 被引量:4
-
4潘维,李莉.补虚化瘀解毒法治疗红斑狼疮60例[J].河南中医,2014,34(10):1967-1968.
-
5孙涛.观察小剂量激素联合环磷酰胺治疗系统性红斑狼疮的疗效[J].临床医药文献电子杂志,2015,2(4):671-672. 被引量:6
-
6朱继发.评价小剂量激素联合甲氨蝶呤治疗系统性红斑狼疮的临床效果[J].中国医药指南,2015,13(14):146-147. 被引量:5
-
7金小红.甲氨蝶呤联合激素、羟氯喹治疗轻、中度活动性系统性红斑狼疮患者的可行性研究[J].当代医学,2015,21(32):138-139. 被引量:5
-
8李丽,邓树忠,王小明.小剂量糖皮质激素对急性胰腺炎HMGB-1 TERM-1表达的影响[J].西部医学,2015,27(12):1829-1831. 被引量:3
-
9董丹.小剂量激素联合环磷酰胺治疗系统性红斑狼疮患者的临床疗效[J].中国药物经济学,2016,11(2):83-84. 被引量:1
-
10高登文.小剂量甲氨蝶呤治疗系统性红斑狼疮的疗效及安全性观察[J].中国实用医药,2017,12(1):127-128. 被引量:8
同被引文献10
-
1吴新华,左晓霞,伍招娣,张卫社,扶琼.妊娠合并系统性红斑狼疮的临床分析[J].中南大学学报(医学版),2006,31(2):271-273. 被引量:6
-
2浦筱雯,狄文.妊娠与系统性红斑狼疮[J].中国妇幼健康研究,2007,18(2):134-136. 被引量:11
-
3朱立娟.糖皮质激素联合羟氯喹治疗系统性红斑狼疮皮疹的疗效观察[J].吉林医学,2010,31(4):495-496. 被引量:7
-
4尹玉竹,周水生,吴玲玲,黄建林,张培珍.妊娠时机对妊娠合并系统性红斑狼疮病情及妊娠结局的影响[J].实用妇产科杂志,2011,27(12):914-917. 被引量:22
-
5赵小娟,汪国生.抗疟药在系统性红斑狼疮中的作用进展[J].中华临床医师杂志(电子版),2012,6(7):84-86. 被引量:7
-
6赵慧霞,王彩虹,罗静,张艳玲,刘国霞,栗江霞,李小峰.羟氯喹在系统性红斑狼疮治疗中的研究进展[J].中国药物与临床,2012,12(7):920-921. 被引量:15
-
7许德清.系统性红斑狼疮诊治的新进展[J].皮肤性病诊疗学杂志,2013,20(6):375-378. 被引量:7
-
8李嘉欣,张卓莉.51例系统性红斑狼疮患者妊娠结局[J].中华临床免疫和变态反应杂志,2014,8(2):123-128. 被引量:9
-
9系统性红斑狼疮诊治指南(草案)[J].中华风湿病学杂志,2003,7(8):508-513. 被引量:217
-
10王雪峰,但东梅,潘晓兰,杨勇.羟氯喹治疗系统性红斑狼疮的疗效观察[J].中国保健营养(下半月),2013,0(6):1408-1408. 被引量:6
二级引证文献4
-
1刘雅姝,曹迪,方圣,赵恒光,黄琨,陈爱军.羟氯喹治疗妊娠合并红斑狼疮疗效及安全性的系统评价[J].重庆医学,2016,45(13):1803-1806. 被引量:12
-
2李春香,孙雅月.他克莫司联合糖皮质激素治疗重症系统性红斑狼疮合并妊娠1例并文献复习[J].中国实用医药,2018,13(1):142-143. 被引量:1
-
3杨凤娜,李晓凤,王芳.羟氯喹联合泼尼松治疗妊娠合并系统性红斑狼疮疗效和安全性的Meta分析[J].中国计划生育和妇产科,2020,12(12):51-56. 被引量:8
-
4覃纬,李敏清.羟氯喹联合泼尼松治疗对妊娠合并系统性红斑狼疮患者母婴结局的影响[J].中华生物医学工程杂志,2021,27(6):621-628. 被引量:9
-
1吴福杉,苏虹梅,陈婷丽.血清胱抑素C和同型半胱氨酸水平与早期糖尿病肾病的关系[J].海南医学,2017,28(2):214-216. 被引量:16
-
2孙莉莉.类风湿伴肺间质病变28例分析[J].实用医学杂志,2004,20(5):520-520. 被引量:1
-
3陆亚华.结缔组织病伴肺间质病变的研究[J].临床荟萃,2002,17(7):383-384. 被引量:1
-
4范平云,李如恒.误诊为消化道疾病的老年人系统性红斑狼疮8例[J].海南医学,2002,13(6):59-59.
-
5陈志民,李建荣.MRI、超声、CT影像学诊断类风湿性关节炎的应用[J].甘肃医药,2017,36(4):287-289. 被引量:2
-
6吴晓东,徐世文.以“肺部感染”的显微镜下多血管炎2例[J].临床肺科杂志,2010,15(7):1045-1046. 被引量:1
-
7谭玲玲,李宛真.中西医结合治疗类风湿关节炎临床应用[J].亚太传统医药,2012,8(2):103-104.
-
8武加标,任敏,肖菁.以肺动脉高压为首发症状的系统性红斑狼疮1例报告并文献复习[J].中国临床新医学,2010,3(8):778-779.
-
9陈慕芝,巴哈尔古丽.力提甫,照日格图.结缔组织病与甲状腺疾病的相关性分析[J].新疆医科大学学报,2015,38(6):739-741.
-
10刘兴振,范洁,赵东宝.类风湿关节炎合并2型糖尿病患者代谢特点分析[J].中华风湿病学杂志,2016,20(2):88-92. 被引量:5